Literature DB >> 17286740

Melatonin decreases nitric oxide production and lipid peroxidation and increases interleukin-1 beta in the brain of mice infected by the Venezuelan equine encephalomyelitis virus.

Nereida Valero1, Luz MarinaEspina, Ernesto Bonilla, Jesus Mosquera.   

Abstract

Melatonin, a potent antioxidant, has shown to be beneficial in murine Venezuelan equine encephalomyelitis (VEE) virus infection. In addition, melatonin can induces the production of interleukin-1 beta (IL-1beta), a cytokine capable of inducing increased expression of inducible nitric oxide synthase; the activity of this enzyme is increased in the brain of mice infected with VEE virus. The aim of this study was to determine the effect of VEE virus on the nitric oxide (NO) production, lipid peroxidation and IL-1beta production in the brain and serum of mice infected with VEE virus, and to investigate the modulatory role of melatonin during this viral infection. Mice were infected with 10 LD(50) of VEE virus and treated with melatonin (500 microg/kg of body weight) starting 3 days before and continuing for 5 days after virus inoculation. Mice were sacrificed on days 1, 3 and 5 postinfection and brains and blood samples were obtained. NO and IL-1beta production and lipid peroxidation levels were measured in perfused brain homogenates and serum. Increased production of brain nitrite was found on days 1, 3 and 5 postinfection and lipid peroxidation products were increased at day 5. Levels of serum nitrite were found elevated on days 3 and 5 postinfection; however, lipid peroxidation products remained similar to basal levels. Melatonin treatment decreased nitrite concentration in brain and serum of infected mice as well as the lipid peroxidation products in the brain. IL-1beta was found to be increased in the brain and serum of infected animals, and melatonin treatment induced higher levels of this cytokine (brain: about 4-fold; serum: about 8-fold). These results may be related to the beneficial effect of melatonin in the VEE experimental disease and address the possible therapeutic potential of the indoleamine in human VEE virus infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17286740     DOI: 10.1111/j.1600-079X.2006.00381.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  8 in total

Review 1.  Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents.

Authors:  S Ramasamy; C Q Liu; H Tran; A Gubala; P Gauci; J McAllister; T Vo
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

2.  Melatonin decreases brain apoptosis, oxidative stress, and CD200 expression and increased survival rate in mice infected by Venezuelan equine encephalitis virus.

Authors:  Milagros Montiel; Ernesto Bonilla; Nereida Valero; Jesús Mosquera; Luz M Espina; Yasmir Quiroz; Melchor Álvarez-Mon
Journal:  Antivir Chem Chemother       Date:  2016-08-08

3.  Antagonistic effect of luzindole in mice treated with melatonin during the infection with the venezuelan equine encephalomyelitis virus.

Authors:  Nereida Valero; Anaís Nery; Ernesto Bonilla; Luz Marina Espina; Leonor Chacin-Bonilla; Florencio Añez; Mery Maldonado; Eddy Meleán
Journal:  Neurochem Res       Date:  2008-07-02       Impact factor: 3.996

4.  Ischemic preconditioning-induced neuroprotection is associated with differential expression of IL-1beta and IL-1 receptor antagonist in the ischemic cortex.

Authors:  Jin A Shin; Eun-Mi Park; Ji-Seung Choi; Sun-Mi Seo; Jihee Lee Kang; Kyung-Eun Lee; Sunghee Cho
Journal:  J Neuroimmunol       Date:  2009-07-09       Impact factor: 3.478

Review 5.  Beneficial actions of melatonin in the management of viral infections: a new use for this "molecular handyman"?

Authors:  Jose Antonio Boga; Ana Coto-Montes; Sergio A Rosales-Corral; Dun-Xian Tan; Russel J Reiter
Journal:  Rev Med Virol       Date:  2012-04-18       Impact factor: 6.989

6.  Pineal hormone melatonin as an adjuvant treatment for COVID‑19 (Review).

Authors:  Marilena Vlachou; Angeliki Siamidi; Aikaterini Dedeloudi; Sofia K Konstantinidou; Ioannis P Papanastasiou
Journal:  Int J Mol Med       Date:  2021-02-12       Impact factor: 4.101

Review 7.  Role of Melatonin on Virus-Induced Neuropathogenesis-A Concomitant Therapeutic Strategy to Understand SARS-CoV-2 Infection.

Authors:  Prapimpun Wongchitrat; Mayuri Shukla; Ramaswamy Sharma; Piyarat Govitrapong; Russel J Reiter
Journal:  Antioxidants (Basel)       Date:  2021-01-02

Review 8.  Melatonin: buffering the immune system.

Authors:  Antonio Carrillo-Vico; Patricia J Lardone; Nuria Alvarez-Sánchez; Ana Rodríguez-Rodríguez; Juan M Guerrero
Journal:  Int J Mol Sci       Date:  2013-04-22       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.